International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a global association of the world’s leading biopharmaceutical companies and national associations. The Biopharmaceutical CEOs Roundtable (BCR) is a global policy forum where the CEOs of IFPMA member companies discuss global health challenges and public health policies impacting biomedical innovation.
Meeting on June 4, 2019 in Tokyo (Japan)
The Biopharmaceutical CEOs Roundtable (BCR) was held in Tokyo on 3-4 June. At the meeting, leaders from four pharma associations (International Federation of Pharmaceutical Manufactures & Associations (IFPMA), the Pharmaceutical Researchers and Manufactures of America (PhRMA), the Japan Pharmaceutical Association (JPMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA)) handed a joint statement to Japanese Prime Minister Shinzo Abe that calls for Japan to 1) accelerate efforts around UHC especially in developing countries, 2) support development in areas with no effective treatments, such as AMR, through partnerships, regulatory harmonization, and predictable and reasonable IP protection rules, and 3) craft legal frameworks that facilitate the use of AI and big data. PM Abe, who briefly attended the CEOs roundtable, expressed the Japanese government’s resolve to push innovation.
In the Press: